Source: Seeking Alpha

Revolution Medicines: Revolution Medicines: Overpriced RAS-Addicted Cancers Maven

Read full article »

Revolution Medicines's Competitors | Revolution Medicines's News | Revolution Medicines's Financials

Followers on Owler

901

Annual Revenue

$5.0-25M

Employees

500-1.0K

President & CEO

Mark A. Goldsmith

CEO Approval Rating

90/100

Revolution Medicines is a California-based biotechnology company that researches and develops novel targeted therapies for the treatment of cancer and infectious diseases.